• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
Contact
  • Home
  • News
  • News
  • NMPA Registration in China
  • Medical Device
  • 2022 Sampling Inspection Plan for Medical Devices

2022 Sampling Inspection Plan for Medical Devices

2022 sampling inspection plan
Friday, 25 March 2022 / Published in Medical Device, News, NMPA Registration in China

2022 Sampling Inspection Plan for Medical Devices

2022 Sampling Inspection Plan was published (No.15-2022) by the NMPA (National Medical Products Administration) on February 22, 2022, for medical devices covering 60 products including electronic endoscope, hollow fiber dialyzer, sodium hyaluronate injection, etc.

Highlights – 2022 sampling inspection plan

  • The main focus of this year’s sampling inspection plan targets medical electrical equipment, in vitro diagnostic reagents, anti-epidemic medical supplies, etc.
  • If there is any objection against the inspection results, only one chance will be given to appeal whilst the application for re-inspection should be submitted within 7 days after receiving the results. However, there will be no arrangement available for re-inspection for oxygenerators, and 4 other products that require risk monitoring sampling inspections.
  • Re-inspection applications would be accepted and handled by the MPA of the respective province where the registrant, filer or legal agent belongs to.
  • The registrant, filer or legal agent should take immediate actions to carry out risk control measures once they receive a failure report from the sampling inspection

By Julie Zhang and Jacky Li. Contact Cisema if you would like to learn more.

Tagged under: Sampling Inspection

What you can read next

FAQ for general cosmetics filing
FAQ for General Cosmetics Filing Released by Beijing MPA
NMPA issues updated guidance for registration of AI software to assist with responding to the Corona-virus pandemic
Draft amendments to TSG T7001 and T7007 published for comments

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • China cosmetics efficacy claims FAQ

    China cosmetics efficacy claims FAQ available to answer key questions

    China cosmetics efficacy claims FAQ is availabl...
  • China cosmetics GMP inspections

    China cosmetics GMP inspections points have been finalised

    China cosmetics GMP inspections points and judg...
  • China medical device quality safety responsibility

    China medical device quality and safety responsibility regulations come into force on March 1, 2023

    China medical device quality and safety respons...
  • China drug standards draft measures

    China drug standards draft measures have been published by the NMPA

    China drug standards draft measures have recent...
  • China special equipment safety supervision

    China special equipment safety supervision – draft provisions released

    China special equipment safety supervision regu...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP
Cookies on Cisema
Learn more about Cisema's Privacy Policy.